Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability: Post Hoc Analysis of 2 Pivotal Clinical Studies.
Fava M, Weiller E, Zhang P, Weiss C.
J Clin Psychopharmacol. 2017 Apr;37(2):276-278. doi: 10.1097/JCP.0000000000000678. No abstract available.
Guidelines for the recognition and management of mixed depression.
Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, Thase ME, Vieta E, Young A, Zimmerman M, McIntyre RS.
CNS Spectr. 2017 Apr;22(2):203-219. doi: 10.1017/S1092852917000165. Epub 2017 Feb 28. Review.
Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials. J Clin Psychopharmacol.
Freeman MP, Pooley J, Flynn MJ, Baer L, Mischoulon D, Mou D, Fava M
2017 Apr;37(2):176-181. doi: 10.1097/JCP.0000000000000669.
Experimental medication treatment approaches for depression.
Ionescu DF, Papakostas GI.
Transl Psychiatry. 2017 Mar 21;7(3):e1068. doi: 10.1038/tp.2017.33. Review.
Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder?
Stauffer VL, Liu P, Goldberger C, Marangell LB, Nelson C, Gorwood P, Fava M.
J Clin Psychiatry. 2017 Mar;78(3):317-323. doi: 10.4088/JCP.15m09972.
Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.
Rutrick D, Stein DJ, Subramanian G, Smith B, Fava M, Hasler G, Cha JH, Gasparini F, Donchev T, Ocwieja M, Johns D, Gomez-Mancilla B. Mavoglurant
Adv Ther. 2017 Feb;34(2):524-541. doi: 10.1007/s12325-016-0468-5. Epub 2017 Jan 2.
Differentiating residual symptoms of depression from adverse events among patients initiating treatment with an antidepressant.
Freeman MP, Fisher L, Clain A, Rabbitt R, Pooley J, Baer L, Fava M.
Ann Clin Psychiatry. 2017 Feb;29(1):28-34.
Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study.
Fava M, Ménard F, Davidsen CK, Baker RA.
J Clin Psychiatry. 2016 Dec;77(12):1695-1701. doi: 10.4088/JCP.15m10470.
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.
Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP.
Mol Psychiatry. 2016 Oct;21(10):1483-4. doi: 10.1038/mp.2016.140. No abstract available.
Response Surface Analysis and Non-Linear Optimization Algorithm For Maximization of Clinical Drug Performance: Application to Extended Release and Long-Acting-Injectable Paliperidone.
Gomeni R, Bressolle F, Fava M.
J Clin Pharmacol. 2016 Oct;56(10):1296-306.
